Nexttrip, Inc. quarterly report, Q2 FY2011

Vollständiges Dokument

Business context and reporting period

The supplied filing is Sigma Labs, Inc.’s unaudited Form 10-Q for the quarter and six months ended June 30, 2011—not a filing identified as Nexttrip, Inc. The company is an early-stage developer of manufacturing and materials technologies, including In Process Quality Assurance (IPQA), and currently earns revenue mainly from engineering consulting. Its target technologies remain under development and are not yet being sold.

Financial results and position

  • Revenue: Q2 revenue was $243,474, versus $34,380 a year earlier. Six-month revenue was $300,513, versus $34,380.
  • Profit and margins: Q2 gross profit was $128,867, a 52.9% gross margin, versus $3,918 and 11.4%. Six-month gross profit was $148,911, a 49.6% margin, versus $3,918 and 11.4%. Net losses were $687,514 for Q2 and $927,482 for six months, compared with $186,339 and $238,282, respectively, in 2010. Reported basic and diluted loss per share was $0.00 for 2011 periods and $0.01 for 2010 periods, rounded as presented.
  • Expenses: Six-month operating expenses totaled $1,076,923, including $400,000 of noncash compensation for restricted shares issued to employees. General and administrative expense was $307,695 and payroll expense was $369,228.
  • Cash flow: Six-month operating cash use was $221,029 and investing cash use was $8,904. Financing provided $1,011,765, primarily from the stock offering. Cash increased by $781,832 to $1,008,100.
  • Liquidity and debt: Working capital was $962,215 at June 30, versus $362,497 at year-end 2010. Current liabilities were $112,255, all accounts payable; the balance sheet reports no debt. No credit facility or committed additional financing was available.
  • Equity: The April private placement issued 55,875,000 shares at $0.02 per share. The company also issued 7,931,250 five-year warrants to its placement agent, exercisable at $0.025 per share. Shares outstanding were 394,667,400 as of August 5, 2011.

Material changes versus prior period

Revenue rose substantially from a low prior-year base, but losses increased as general and administrative costs, payroll and noncash share compensation grew. The company raised $1,011,765 net through an equity offering, increasing cash and working capital. The filing’s business combination and reverse-purchase accounting mean comparisons with 2010 may not reflect equivalent operating periods.

Outlook, risks and unusual items

  • Management expects general and administrative, payroll and noncash compensation expenses to increase as operations and marketing expand.
  • As of August 5, the company reported five active consulting contracts and expected up to $239,604 of revenue for the remainder of 2011. Some contracts are fixed-price, exposing the company to cost-estimation and execution risk.
  • Management believed available funds and expected consulting receipts would cover operating and administrative expenses through the end of 2011. Longer-term funding depends on consulting revenue, future securities sales and successful commercialization; no additional capital commitments were disclosed.
  • The company had not achieved profitable operations. The filing identifies continued operations as dependent on expanding income opportunities and says management expects additional contracts to support profitability.
  • At June 30, the company reported approximately $1.28 million of net operating loss carryforwards, with a full valuation allowance against the related tax benefit. Ownership changes could limit use of the carryforwards.
  • The filing reports no legal proceedings, market-risk disclosure, defaults, or future minimum operating-lease payments. Management assessed disclosure controls as effective at a reasonable assurance level.

Important facts for investors to verify

  1. Confirm issuer identity: the provided filing names Sigma Labs, Inc., while the request metadata names Nexttrip, Inc.
  2. Review the private-placement terms, placement-agent warrants and share issuances, including the resulting dilution and equity-plan awards.
  3. Assess whether the five consulting contracts and expected remaining-2011 revenue materialized, and whether fixed-price work was profitable.
  4. Evaluate cash runway and funding needs against management’s dependence on future consulting revenue and additional securities sales.
  5. Track commercialization progress, operating losses and rising expense expectations; the filing provides no quantified profitability guidance.